BioSpace News Archive

Report on Transactions With ALK-Abelló A/S B-Shares and Associated Securities by Managerial Staff

ALK-Abelló is reporting the following transactions.

December 7, 2017

·

1 min read

Glenmark Pharmaceuticals Announces Dosing of First Patient With Investigational Immuno-Oncology Agent GBR 1342

This first-in-human, open-label study’s primary objective is to assess the safety and tolerability of increasing doses of GBR 1342 in multiple myeloma patients until a maximum tolerated dose is reached.

December 7, 2017

·

2 min read

Deals

KKR Completes Acquisition of PharMerica

As a result of the completion of the acquisition, PharMerica shareholders will receive an amount in cash equal to $29.25 per share of PharMerica common stock, without interest.

December 7, 2017

·

3 min read

Drug Development

CRISPR Therapeutics Submits First Clinical Trial Application for a CRISPR Gene-Edited Therapy, CTX001 in β-thalassemia

CTX001 is an investigational CRISPR gene-edited autologous hematopoietic stem cell therapy for patients suffering from β-thalassemia and sickle cell disease.

December 7, 2017

·

5 min read

Business

Median Technologies Inks a Research Collaboration Agreement for Lung Cancer Screening Programs With Xingtai People’s Hospital, Xingtai City, China

Within the frame of the agreement, Median’s MediScan® image analysis technology will be used to conduct lung cancer screening programs organized under the aegis of Xingtai People’s Hospital in Xingtai City.

December 7, 2017

·

3 min read

Business

Generex Announces Collaboration With Shenzhen BioScien Pharmaceuticals to Develop and Commercialize the AE37 Immunotherapeutic Vaccine for the Treatment of Prostate Cancer in China

Shenzhen BioScien will pay Generex a non-refundable, up-front license fee of $700,000 USD.

December 7, 2017

·

4 min read

Pluristem to Present Data on PLX-R18 in Treatment of Acute Radiation Syndrome at ASH’s Annual Meeting

The results of the study will be presented during Program Session 506: Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells.

December 7, 2017

·

5 min read

GUERBET : Gadolinium-Based Contrast Agents: Update on MHLW Decision in Japan

For all GBCAs, “the necessity of MRI scan using gadolinium-based contrast agents should be determined carefully” as stated in the Japanese new package insert.

December 7, 2017

·

3 min read

Business

Bertin and Zymo Research Announce New Collaboration

Zymo Research Corp. and Bertin announce a collaboration that ensures the sample lysis step in the microbiome workflow is complete and unbiased.

December 7, 2017

·

2 min read

Drug Development

BlackThorn Therapeutics Presents Preclinical and Clinical Data From Its First-in-Class NOPR Antagonist at American College of Neuropsychopharmacology Annual Meeting

Preclinical study results also showed that NOPR antagonism improved motor symptoms in a non-human primate model of Parkinson’s disease.

December 7, 2017

·

5 min read